All Episodes
Featured
Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease.
•44:34

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease.

0:00 / 44:34

Tonight's Episode

Got dry mouth, dry eyes, joint pains, chronic fatigue? Get checked for often-undiagnosed Sjögren’s Disease. Watch this video podcast with rheumatologist & Sjogren's expert, Sara McCoy, M.D. discussing Novartis #ianalumab FDA Breakthrough Therapy Designation. More information is available at: https://www.novartis.com/news/media-releases/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-sjogrens-diseaseandhttps://sjogrens.org/andhttps://www.uwhealth.org/providers/sara-s-mccoy-mdandhttps://www.novartis.com/us-en/patients-and-caregiversWatch all 145 episodes of the #DoctorPodcasts || Cykiert Files video podcast interview show with physicians, scientists, healthcare specialists, entrepreneurs and other experts http://Doctorpodcasts.com/index-of-doctoof-doctoof-doctoof-doctorpodcasts-episodes. Please SUBSCRIBE & FOLLOW @DoctorPodcasts . Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments, suggestions, reviews and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.#Sjogrens

#SjogrensSyndrome

#SjogrensDisease

#Autoimmune

#AutoimmuneDisease

#Rheumatology

#DryEyesDryMouth

#ChronicFatigue

#InvisibleIllness

#ChronicIllness

#RareDiseaseAwareness

#BreakthroughTherapy

#PatientEducation

#MedicalPodcast

#HealthPodcast

#WomenAndAutoimmunity

#LivingWithSjogrens

#RheumLife